Finally, the dynamic of expression of PR in the ovarian cancer cells and the cells encompassing the accompanying tumor stroma is crucially needed in order to define whether direct or paracrine cancer–stroma interactions explain the antiproliferative actions of antiprogestins. This evidence concerns the gene PGR and neoplasm.